Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FMWAJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,552
Award facts
- Contract value 100% obligated
- $14,551.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units, with a ceiling value of $14,551.52. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is positioned to be completed by July 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies covering multiple therapeutic domains, ranging from specialty medications and vaccines to medical devices. All reviewed contract awards reflect the company's capability to meet federal procurement requirements through open competition, with consistent use of firm fixed-price delivery orders. This particular delivery order for Ondansetron ODT, a commonly used antiemetic medication, supports ongoing pharmaceutical supply needs for Defense Department healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FMWAJ?
SPE2DB25FMWAJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FMWAJ worth?
The government has obligated $14,552 on SPE2DB25FMWAJ.
Is contract SPE2DB25FMWAJ an order under another contract?
Yes. SPE2DB25FMWAJ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMWAJ competed?
The extent of competition for SPE2DB25FMWAJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award